‘HOT’ stock: Sigma Healthcare (SIG)
Raymond Chan, Private Client Adviser & Head of Asian Desk at Morgans highlights that Sigma Healthcare’s (SIG) year-to-date update shows continued strong momentum.
Browse current and previous editions of Switzer Report
Raymond Chan, Private Client Adviser & Head of Asian Desk at Morgans highlights that Sigma Healthcare’s (SIG) year-to-date update shows continued strong momentum.
This week, I'm looking at the rest of the ASX-listed cardiac health cohort – all of which have different angles in heart health.
Switzer Investing TV aired its 18 May 2026 edition with a panel of expert investors. Here's what they're looking at on the market, and all their latest stock tips.
Is anyone surprised that our market was a loser this week, with the Budget colliding with rising interest rates and the Treasurer telling us our economy is slowing to 1.75% from a previous guess of 2.25%? Throw in the stalemate in the Strait of Hormuz and the bigger question has to be this: how come US markets rose this week?
I want to share with you a market assessment of how the Budget might affect shares. This is the analysis from stockbroking firm Morgans. I’ve added a bit of Switzer flavour to the piece.
These Federal Budget capital gains tax changes encourage a greater focus on long-term income investing.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why he considers Sandfire Resources (SFR) a BUY.
With the $A at 72 cents, is it too late to select a currency hedged option for international shares? Are the superannuation caps being increased next year? What do the major brokers think about Goodman Group? Why has ANZ increased its franking percentage from 70% to 75%, and why is it the only major bank not to fully frank its dividends?
In this week’s Boom Doom Zoom, we take your questions on the Federal Budget and how it might affect the market and your investments.
With my financial planning clients, I’ve been increasing the exposure to 3-month term deposits because I expect more rate rises and when the rising cycle looks at the top, I’ll go for longer dated term deposits. Here are my thoughts in more detail.
Let me take a look at the big banks today and tell you my thoughts on the best two.
Here are three companies in the thriving (though small) sector of the ASX biotech world that are working to get to the heart of cardiac health. All three have unique approaches to it.
Raymond Chan, Private Adviser & Head of Asian Desk at Morgans, explains why Morgans considers REA a BUY.
Following interim reporting, ANZ Bank, National Australia Bank and Westpac feature prominently with three, two and one upgrades, respectively.
On the eve of the Federal Budget, four expert guests joined Paul Rickard to discuss where investors should be positioning across ETFs, individual stocks and fixed income.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.